Presented by Marylise Boutros at the ASGE Joint Panel: Endoscopic Management of Colon Lesions held during the 2017 SAGES Annual Meeting in Houston, TX on Saturday, March 25, 2017
Keyword(s): abdomen, advanced adenomas, advanced neoplasia, asymptomatic, benign, biopsy, bowel prep, British guidelines, Cancer Care Ontario, CARE study, CEA, chest, clearance, colon, colon polyps, colonoscopy screening, colonoscopy surveillance, colorectal cancer, colorectal surgery, cost effectiveness, CRC, CRC surgery, CT colonography, curative resection, DFS, diagnostic, disease free survival, endoscopic resection, endoscopists, endoscopy, false positive result, flex sig, flexible sigmoidoscopy, follow-up, GILDA trial, guidelines, H&P, HGD, high grade dysplasia, high risk, histology, history & physical, imaging, incomplete resection, intraluminal, lesions, management, mesorectal, meta-analysis, metachronous cancer, National Cancer Institute, NCI Pooling Project, pathology, pelvis, physical exam, piecemeal excision, polypectomy, preoperative clearance, preoperative work-up, proctoscopy, QoL, quality of life, rectal cancer, rectum, recurrence rate, reoperation, resection, retrospective study, scar, specimen, synchronous lesion, task force, tubular adenoma, TVA, U.S., United States, VA, Veterans Affairs, villous adenoma
Baseline colonoscopy–23 sec Gastroenteroloy 2004
Advanced adenoma–1:47
# of polyps–2:21 Gastroenterology 2006
Size of polyps–3:56
TVA & HGD histology–4:40
HGD histology–5:42 Colorectal Dis 2011
Surveillance for advanced adenoma–6:01
Acutal surveillance–6:57
Incomplete/piecemeal excision–7:30 Gastroenterology 2013
Clin Gastroenterol Hepatol 2006
Surveillance after CRC resection–9:34
Preop clearance of the colon & rectum–10:02 Am J Surg 1984
Recurrence risk–11:04 DCR 1996
Metachronous cx risk–12:07
Citation–12:27 Gastroenterology 2008
Cure for metachronous cx–13:05
Removal of metachronous polyps–13:35 Surg Oncol 1992
Optimal surveillance interval–16:05 GIE 2009
Cost-effectiveness of surveillance–19:08
Surveillance & QoL–19:45 Br J Cancer 1997
Overall benefit of surveillance–20:11